TFRC and neoplasm: Mechanistically, high TFRC expression negatively correlates with the infiltration levels of key anti-tumor immune cells such as CD8+ T cells and positively correlates with immunosuppressive cells like Th2 cells, suggesting it promotes disease progression and poor prognosis by modulating the tumor immune microenvironment (29, 30).